×
About 13,570 results

ALLMedicine™ Subarachnoid Hemorrhage Center

Research & Reviews  4,763 results

Risk Factors for Delayed Cerebral Ischemia in Good-Grade Patients With Aneurysmal Subar...
https://doi.org/10.1161/JAHA.122.027453
Journal of the American Heart Association; Rautalin I, Juvela S et. al.

Nov 30th, 2022 - Background A subset of good-grade patients with aneurysmal subarachnoid hemorrhage (aSAH) develop delayed cerebral ischemia (DCI) that may cause permanent disabilities after aSAH. However, little is known about the risk factors of DCI among this s...

Characteristics of subarachnoid hemorrhage associated with COVID-19 infection: A system...
https://doi.org/10.1016/j.jstrokecerebrovasdis.2022.106904
Journal of Stroke and Cerebrovascular Diseases : the Offi... Lim MJR, Yeo J et. al.

Nov 29th, 2022 - Subarachnoid hemorrhage (SAH) has been reported as a neurological manifestation in 0.1% of COVID-19 patients. This systematic review investigated the outcomes and predictive factors of SAH in patients with COVID-19. An electronic literature search...

Quercetin Alleviates Subarachnoid Hemorrhage-induced Early Brain Injury via Inhibiting ...
https://doi.org/10.1002/ar.25130
Anatomical Record (Hoboken, N.J. : 2007); Jiao D, Xu J et. al.

Nov 29th, 2022 - Early brain injury (EBI) refers to a series of pathophysiological brain lesions that occur within 72 hours after subarachnoid hemorrhage (SAH), which is an extremely crucial factor in the poor prognosis of patients. In EBI, ferroptosis has been pr...

Duration and characteristics of persistent headache following aneurysmal subarachnoid h...
https://doi.org/10.1111/head.14418
Headache Gaastra B, Carmichael H et. al.

Nov 26th, 2022 - To assess the long-term frequency, prognosis, and phenotype of persistent headache following aneurysmal subarachnoid hemorrhage (aSAH). Very little is known about long-term headache following aSAH with no studies looking beyond 3 years. Retrospect...

Cervical sympathectomy to treat cerebral vasospasm: a scoping review.
https://doi.org/10.1136/rapm-2022-103999
Regional Anesthesia and Pain Medicine; Bombardieri AM, Heifets BD et. al.

Nov 25th, 2022 - Delayed cerebral ischemia (DCI) is the second-leading cause of death and disability in patients with aneurysmal subarachnoid hemorrhage (aSAH), and is associated with cerebral arterial vasospasm (CAV). Current treatments for CAV are expensive, inv...

see more →

Guidelines  4 results

ACR Appropriateness Criteria® Cerebrovascular Diseases-Aneurysm, Vascular Malformation,...
https://doi.org/10.1016/j.jacr.2021.08.012
Journal of the American College of Radiology : JACR; , Ledbetter LN et. al.

Nov 20th, 2021 - Cerebrovascular disease is a broad topic. This document focuses on the imaging recommendations for the varied clinical scenarios involving intracranial aneurysms, vascular malformations, and vasculitis, which all carry high risk of morbidity and m...

Subarachnoid hemorrhage guidance in the era of the COVID-19 pandemic - An opinion to mi...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7274572
Journal of Stroke and Cerebrovascular Diseases : the Offi... Nguyen TN, Jadhav AP et. al.

Aug 19th, 2020 - Aneurysmal subarachnoid hemorrhage (SAH) patients require frequent neurological examinations, neuroradiographic diagnostic testing and lengthy intensive care unit stay. Previously established SAH treatment protocols are impractical to impossible t...

Canadian Stroke Best Practice Recommendations: Hyperacute Stroke Care Guidelines, Updat...
https://doi.org/10.1111/ijs.12551
International Journal of Stroke : Official Journal of The... Casaubon LK, Boulanger JM et. al.

Jul 7th, 2015 - The 2015 update of the Canadian Stroke Best Practice Recommendations Hyperacute Stroke Care guideline highlights key elements involved in the initial assessment, stabilization, and treatment of patients with transient ischemic attack (TIA), ischem...

Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for he...
https://doi.org/10.1161/STR.0b013e3182587839
Stroke Connolly ES, Rabinstein AA et. al.

May 5th, 2012 - The aim of this guideline is to present current and comprehensive recommendations for the diagnosis and treatment of aneurysmal subarachnoid hemorrhage (aSAH). A formal literature search of MEDLINE (November 1, 2006, through May 1, 2010) was perfo...

see more →

Drugs  23 results see all →

Clinicaltrials.gov  342 results

Safety, Feasibility, and Efficacy of Non-invasive Vagus Nerve Stimulation (nVNS) in the Treatment of Aneurysmal Subarachnoid Hemorrhage
https://clinicaltrials.gov/ct2/show/NCT05103566

Oct 7th, 2022 - This is a single-site, single-arm, open-label pilot study assessing the safety, feasibility, and efficacy of non-invasive vagus nerve stimulation (nVNS), gammaCore, for the acute treatment of aneurysmal subarachnoid hemorrhage (SAH). The hypothesi...

FILtration of Subarachnoid Hemorrhage Via SpinaL CAtheteR Extension
https://clinicaltrials.gov/ct2/show/NCT03607825

Oct 6th, 2022 - The PILLAR-XT study is designed to further confirm safety and characterize efficacy of Neurapheresis therapy. The study works in tandem with the current SOC treatments for SAH and does not detract from the established care pathways, or deny enroll...

Ferritin and Iron Burden in SAH sIRB
https://clinicaltrials.gov/ct2/show/NCT03754725

Oct 4th, 2022 - I) SIGNIFICANCE 1) Significance and Incidence and Burden of the disease Intracranial aneurysm is a prevalent disease estimated around 2-5% of the population. Aneurysm rupture leads to aneurysmal subarachnoid hemorrhage , which have a tremendous im...

The Effect of Huperzine A Injection on Postoperative Cognitive Dysfunction in Patients With Aneurysmal Subarachnoid Hemorrhage: a Pilot Study
https://clinicaltrials.gov/ct2/show/NCT05560373

Sep 29th, 2022 - Description: This is a randomized, controlled, single center, exploratory clinical trial. The subjects are divided into surgical treatment group and interventional treatment group. Each group is divided into test group and control group. The test ...

Neuroinflammatory Response and Headache Control in Patients After Subarachnoid Hemorrhage
https://clinicaltrials.gov/ct2/show/NCT03604276

Sep 21st, 2022 - Persistent headache is a significant medical issue that affects 20% of patients who survive an aneurysmal subarachnoid hemorrhage (SAH). This headache may last years, severely affecting quality of life. Laboratory evidence suggests that the persis...

see more →

News  272 results

Flu Vaccination Associated With Reduced Stroke Risk
https://www.medscape.com/viewarticle/983953

Nov 11th, 2022 - Dr Jessalyn Holodinsky Influenza vaccination is associated with a reduced risk of stroke among adults, even if they aren't at high risk for stroke, according to new research. The risk of stroke was about 23% lower in the 6 months following a flu s...

New Heart Pump Approved; Scams After a Stroke; Cardiac Rehab Falls Further
https://www.medpagetoday.com/cardiology/prevention/101525

Nov 1st, 2022 - Abiomed announces FDA approval of the Impella RP Flex with SmartAssist with the indication for temporary right ventricular support in people with acute right heart failure. The American College of Cardiology provides a framework for treating patie...

Taylor Swift Loses 'Fat'; Changing Addiction Language; Exercise and COVID Vaccine
https://www.medpagetoday.com/endocrinology/obesity/101451

Oct 27th, 2022 - Note that some links may require subscriptions. A Taylor Swift video was edited to remove a controversial moment in which a scale displayed the word "fat" when she stepped on it. (CNN) While employer-sponsored health insurance costs were relativel...

Concerning Trend of Growing Subarachnoid Hemorrhage Rates in Black People
https://www.medscape.com/viewarticle/983140

Oct 27th, 2022 - Rates of subarachnoid hemorrhage (SAH) are increasing, particularly in Black people, new research suggests. Results of a new study based on hospital discharge data show Black people have disproportionately high rates of SAH vs other racial groups....

Cilta-cel Induces Favorable MRD Negativity Rates in Heavily Pretreated Myeloma After Prior BCMA-Directed Therapy
https://www.onclive.com/view/cilta-cel-induces-favorable-mrd-negativity-rates-in-heavily-pretreated-myeloma-after-prior-bcma-directed-therapy

Aug 28th, 2022 - Ciltacabtagene autoleucel (cilta-cel; Carvykti) elicited high rates of minimal residual disease (MRD) negativity in patients with heavily pretreated multiple myeloma who received prior treatment with a BCMA-targeted therapy, according to data from...

see more →

Patient Education  24 results see all →